News | Point-of-Care Ultrasound (POCUS) | March 10, 2021

Fujifilm Sonosite Launches New Point-of-Care Ultrasound System

The system has an adaptable form factor, embedded workflow, and the most advanced image clarity Sonosite has ever offered

Fujifilm Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, has announced the launch of the new Sonosite PX ultrasound system in Canada.

March 10, 2021 — Fujifilm Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, has announced the launch of the new Sonosite PX ultrasound system in Canada. Sonosite PX is the next generation in Sonosite POCUS, with the most advanced image clarity ever seen in a Sonosite system, a suite of workflow efficiency features, and an adaptable form factor.  

"Every aspect of Sonosite PX was designed specifically for the clinicians on the front lines of medicine. We designed Sonosite PX as a tool to help clinicians in all fields of medicine to treat patients more effectively where it matters most – at the point of care," said Rich Fabian, President and Chief Operating Officer of Fujifilm Sonosite, Inc. "To optimize clinician ergonomics and improve efficiency, the system has an innovative and adaptable work surface that can be used in a horizontal or vertical position based on the situational needs of the exam. The exceptional image clarity is the result of a new proprietary imaging technology – seeing anatomy more clearly with Sonosite PX provides an unparalleled level of confidence for diagnostic and procedural applications."

Sonosite PX launches with a new family of transducers, such as the L19-5, the highest frequency transducer Sonosite has ever produced, providing well-defined near field resolution and a minimum scan depth of 1 cm. With a small footprint of 20 mm the L19-5 transducer is ideal for superficial scanning such as vascular access, and pediatrics and musculoskeletal exams.

As with all Sonosite POCUS systems, Sonosite PX is built to the legendary durability, reliability, and ease of use standards that clinicians around the world depend upon.

The ultrasound system and the new family of transducers are drop-tested to one meter and the work surface is sealed to the edge for simplified cleaning and disinfection.  When mounted on the specialized stand, Sonosite PX has an adaptable work surface position for optimal clinician ergonomics while a small footprint and adjustable height allows for closer bedside access. Information essential to completing an exam including patient information, reports, and worksheets, is intuitively placed in one location, saving clinicians time and effort when navigating the ultrasound system user interface.

Diku Mandavia, M.D., FACEP, FRCPC, Senior Vice President and Chief Medical Officer of Fujifilm Sonosite, Inc. explained, "Clinicians are continually expanding their use of ultrasound. With Sonosite PX, they can use one ultrasound system for different workflows because it adapts to fit their diverse needs." The Sonosite PX user interface is simplified to show most-used controls, calculations, and annotations. Dr. Mandavia continued, "The system has two cardiac options that allow clinicians to choose between gathering targeted information about the heart to determine overall patient well-being, or investigate specific cardiac conditions with more comprehensive calculations that provide detailed analysis of the structure and function of the heart. This allows clinicians to select the cardiac exam type that best fits their individual workflow needs. Furthermore in keeping with our commitment to education, we have greatly expanded our 3-D animation educational videos which are very important to new users. Sonosite PX has more than 140 onboard scan-along education tutorials; the most expansive library in any point-of-care system."

Recognizing the importance of efficient documentation to the electronic health record (EHR), Sonosite PX has been designed for onboard documentation of ultrasound findings at the bedside. Sonosite PX integrates seamlessly with the company's Sonosite Synchronicity solution, a workflow manager for POCUS that supports seamless credentialing, quality assurance, and billing across departments and institutions.

For more information: www.sonosite.com

 

Related Content

Cloud services have been utilized within healthcare organizations for more than a decade. Now with the growth of artificial intelligence (AI) it is very common to see organizations adopting cloud services.

Getty Images

Feature | Information Technology | September 14, 2021 | By Jef Williams
Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

Outlook for 2021 and Beyond. As displayed in the figure below, these six market drivers are projected to result in teleradiology reading service volumes increasing by 21% in 2021 and nearly doubling by 2025. Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.

News | Teleradiology | September 14, 2021 | By Arun Gill
To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud
News | Information Technology | September 14, 2021 | By Kumar Goswami
As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.

Courtesy of Grand View Research

Feature | Magnetic Resonance Imaging (MRI) | September 14, 2021 | By Melinda Taschetta-Millane
Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Feature | Radiology Imaging | September 14, 2021 | By Brendon McHugh
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated AI decision support tool for cardiac ultrasound.
News | Cardiovascular Ultrasound | September 14, 2021
September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S.
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
New recommendations will help provide more reliable, reproducible results for MRI-based measurements of cartilage degeneration in the knee, helping to slow down disease and prevent progression to irreversible osteoarthritis, according to a special report published in the journal Radiology

Knee cartilage compartments with anatomic labels implemented in lateral (left side), central (middle), and medial (right side) MRI obtained with an intermediate weighted fat-saturated fast-spin-echo sequence (top row) and a spin-lattice relaxation time constant in rotating frame (T1r) magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots sequence (bottom row, T1r maps). Study was performed without administration of intravenous gadolinium-based contrast material. The lateral femur (LF)/medial femur (MF) and lateral tibia (LT)/medial tibia (MT) can be further divided into subcompartments on the basis of meniscus anatomy according to Eckstein et al. P = patella, T = trochlea.  Chalian et al, Radiology 2021 301; 7 ©RSNA 2021

News | Magnetic Resonance Imaging (MRI) | September 10, 2021
September 10, 2021 — New recommendations will help provide more reliable, reproducible results for...
This certification, which covers Agfa HealthCare’s Class IIa Enterprise Imaging and XERO Viewer solutions, ensures that Agfa HealthCare can continue to deliver to customers innovative solutions that meet their real challenges and address their needs and requirements.
News | Enterprise Imaging | September 09, 2021
September 9, 2021 — Agfa HealthCare is proud to be one of the first companies to receive the new European Medical Dev